Related Experiment Video

Updated: May 28, 2026

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
12:38

Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies

Published on: July 19, 2007

Meeting the need for regenerative therapies I: target-based incidence and its relationship to U.S. spending,

Nancy Parenteau1, Janet Hardin-Young, William Shannon

  • 1Parenteau BioConsultants , LLC, Fair Haven, Vermont, USA.

Tissue Engineering. Part B, Reviews
|November 3, 2011
PubMed

Insights

Regenerative therapies show promise but commercial success is uncertain. Strategic data on opportunities is needed for effective translation and clinical adoption of these advanced medical treatments.

Area of Science:

  • Regenerative medicine
  • Biotechnology
  • Medical innovation

Background:

  • Regenerative therapies hold significant theoretical potential for advancing medicine.
  • However, their successful translation into commercial therapeutics remains a challenge.
  • Lack of accessible data hinders strategic decision-making for research scientists and startups.

Purpose of the Study:

  • To assess the opportunity landscape for regenerative therapies.
  • To evaluate medical needs and technological feasibility through a target-based estimation.
  • To analyze U.S. research spending, productivity, and innovation in the field.

Main Methods:

  • Target-based estimation of therapeutic opportunities.
  • Analysis of U.S. research funding, productivity metrics, and innovation trends.
  • Evaluation of barriers to clinical translation and adoption.

Main Results:

  • The target-based opportunity estimate is crucial for evaluating medical need and feasibility.
  • U.S. basic research in regenerative medicine could be enhanced by greater interdisciplinarity.
  • Significant barriers impede the translation of regenerative therapies into high-value, clinically adopted treatments.

Conclusions:

  • Effective translation of regenerative therapies requires strategic data on market opportunities.
  • Increased interdisciplinarity in U.S. research is recommended to boost innovation.
  • Overcoming translation barriers necessitates integrating engineering, science, business, and clinical practice.

More Related Videos

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery05:13

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Overview of Regeneration and Repair01:19

Overview of Regeneration and Repair

Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Whole Body Regeneration01:33

Whole Body Regeneration

Regeneration is the process of restoring injured or lost tissues, organs, or body parts. While simpler organisms generally show greater ability to regenerate their whole body, few complex animals show similarly exceptional regeneration. For example, planarian flatworms have a unique regenerative potential making them a popular study organism among biologists to understand the mechanisms of whole body regeneration. Other organisms, such as hydra, also show extreme regeneration potential; even...
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...